by NAPP Executive | Nov 21, 2025 | News, Reports, Resources
The RANZCP put out a statement on the NZ ban on puberty blockers. See below link. https://www.ranzcp.org/news-analysis/puberty-blocker-pause-could-harm-vulnerable-young-people-psychiatrists-say Our NAPP response. Unlike the National Association of Practising...
by NAPP Executive | Nov 19, 2025 | News, Newsletters
Dear Colleagues, At our AGM last year, I outlined our plans for 2025. It is appropriate now to reflect on what has been achieved over the past year and to consider our direction for 2026. In 2025 we delivered the professional development program that we proposed. We...
by NAPP Executive | Sep 14, 2025 | News, Reports, Resources
The Executive Summary is immediately below. More details of the statement can be found in our submission at the following link. Subject: Proposal for Inclusion of a New NSQHS Standard on Psychological Safety, Trauma-Informed Care, and Protection of Clinician Wellbeing...
by NAPP Executive | Aug 20, 2025 | News, Resources
Medical Benefits Scheme – Items for Telehealth Consultations for Private Hospital Inpatients Dear MBS Clinical Policy Section, the National Association of practising psychiatrists has taken the viewpoints of our members, particularly those who look after private...
by NAPP Executive | Jul 29, 2025 | Media Release, News
Several state governments are liberalising the prescription of stimulant medications for attention deficit hyperactivity (ADHD) disorder in children and adults. Most states have a restriction that the medications can only be instituted by paediatricians or...
